Table 1. Baseline characteristics of patients with CAD and controls.
| Variables | All subjects | CAD | Non-CAD | P |
|---|---|---|---|---|
| N (male %) | 183 (68.5) | 153 (71.1) | 30 (57.7) | 0.06 |
| Age (years) | 61±10 | 61±10 | 61±12 | 0.66 |
| SBP (mmHg) | 135±20 | 135±19 | 136±21 | 0.68 |
| DBP (mmHg) | 76±12 | 75±12 | 77±12 | 0.49 |
| HR (beats/min) | 72±12 | 72±12 | 73±12 | 0.19 |
| BMI (kg/m2) | 22±10 | 23±10 | 22±10 | 0.81 |
| Smoking n (%) | 124 (46.4) | 105 (48.8) | 19 (36.5) | 0.11 |
| Drinking n (%) | 81 (30.3) | 63 (29.3) | 18 (34.6) | 0.47 |
| HBP n (%) | 125 (46.8) | 104 (48.4) | 21 (40.4) | 0.30 |
| Diabetes n (%) | 71 (26.6) | 61 (28.4) | 10 (19.2) | 0.18 |
| Gensini Score | 96±85 | 111±85 | 34±50 | <0.01 |
| TG (mmol/l) | 3.9±1.0 | 3.9±1.0 | 3.9±1.0 | 0.79 |
| HDL (mmol/l) | 1.1±0.4 | 1.1±0.5 | 1.2±0.3 | 0.20 |
| LDL (mmol/l) | 2.3±0.8 | 2.4±0.8 | 2.0±0.5 | <0.01 |
| FBG (mmol/l) | 5.9±1.9 | 6.0±2.0 | 5.6±1.6 | 0.12 |
| NTproBNP (ng/ml) | 402±761 | 435±835 | 264±296 | 0.15 |
| ACEI/ARB n (%) | 143 (53.6) | 119 (55.3) | 24 (46.2) | 0.32 |
| CCB n (%) | 93 (34.8) | 70 (32.6) | 23 (44.2) | 0.11 |
| Nitrates n (%) | 162 (60.1) | 135 (62.8) | 27 (51.9) | 0.15 |
| Statins n (%) | 26 (99.3) | 214 (100.0) | 51 (98.1) | 0.28 |
| Anti-diabetic agents n (%) | 71 (26.6) | 61 (28.4) | 10 (19.2) | 0.18 |
Abbreviations: ACEI/ARB-angiotensin converting enzyme inhibitor/angiotensin receptor blocker; BMI-body mass index; CAD-coronary heart disease; CCB-calcium channel blockers; DBP-diastolic blood pressure; FBG-fast blood glucose; HDL-high-density lipoprotein; HR-heart rate; LDL-low-density lipoprotein; SBP-systolic blood pressure; TC, total cholesterol; TG-total triglyceride.